Publications by authors named "Luz Marina Zuluaga"
Use of Intralesional and Perilesional Human Recombinant Epidermal Growth Factor (hrEGF) in the Local Treatment of Venous Ulcer - Review Article - Expert Recommendation.
Maria Teresa Cacua Sanchez Lina M Vargas Abello Álvaro Orrego Paola Ortiz Héctor Segura Luz Marina Zuluaga
Vasc Health Risk Manag
September 2023
Article Synopsis
- Venous Ulcers (VU) are a common type of leg ulcer caused by problems like venous hypertension or valve failure, making up 60-80% of all cases.
- While traditional treatment methods that target the underlying causes are standard, about 30% of these ulcers don't heal with those approaches, leading to the exploration of growth factors as additional treatments.
- A review of various studies from 2002 to 2022 found that topical, intralesional, and perilesional applications of growth factors could be effective, with the latter suggesting a promising alternative treatment for venous ulcers.